When GIGYF1 is reduced, as is the case in individuals carrying pLOF variants, GRB10 presumably inhibits insulin signaling to a greater degree thereby reducing the action of insulin in its target tissues and leading to increased risk of T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.